MicroRNA expression profile and identification of novel microRNA biomarkers for metabolic syndrome.
Metabolic syndrome
bioinformatics
biomarker
high-throughput sequencing
miRNA
Journal
Bioengineered
ISSN: 2165-5987
Titre abrégé: Bioengineered
Pays: United States
ID NLM: 101581063
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
The lack of efficient biomarkers is the main reason for the inaccurate early diagnosis and poor treatment outcomes of patients with metabolic syndrome (MetS). The current study aimed to identify several novel microRNA (miRNA) biomarkers for metabolic syndrome via high-throughput sequencing and comprehensive bioinformatics analysis. Through high-throughput sequencing and differentially expressed miRNA (DEM) analysis, we first identified two upregulated and 36 downregulated DEMs in the plasma samples of patients with MetS compared to the healthy volunteers. Additionally, we also predicted 379 potential target genes and subsequently carried out enrichment analysis and protein-protein interaction network analysis to investigate the signaling pathways and functions of the identified DEMs as well as the interactions between their target genes. Furthermore, we selected two upregulated and top 10 downregulated DEMs with the highest |log2FC| values as the key microRNAs, which may serve as potential biomarkers for MetS. RT-qPCR was performed to validated these result. Finally, hsa-miR-526b-5p, hsa-miR-6516-5p was identified as the novel biomarkers for MetS.
Identifiants
pubmed: 34269146
doi: 10.1080/21655979.2021.1952817
pmc: PMC8806888
doi:
Substances chimiques
Biomarkers
0
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3864-3872Références
Biol Rev Camb Philos Soc. 2016 May;91(2):409-28
pubmed: 25631495
Endocr Rev. 2008 Dec;29(7):777-822
pubmed: 18971485
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Mol Cells. 2016 May 31;39(5):375-81
pubmed: 27117456
Nutrients. 2019 Aug 08;11(8):
pubmed: 31398873
Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R154-61
pubmed: 16141308
Circ J. 2004 Nov;68(11):975-81
pubmed: 15502375
J Clin Invest. 2019 Feb 1;129(2):834-849
pubmed: 30667374
Endocrinology. 2007 Jun;148(6):2955-62
pubmed: 17317777
Metab Syndr Relat Disord. 2015 Nov;13(9):373-80
pubmed: 26512756
Int J Endocrinol. 2014;2014:715148
pubmed: 24883062
Cardiovasc Res. 2014 Jul 15;103(2):324-36
pubmed: 24788416
Steroids. 2017 Dec;128:105-113
pubmed: 28988119
Mediators Inflamm. 2013;2013:367245
pubmed: 23365487
Biochem Biophys Res Commun. 2015 Oct 2;465(4):670-7
pubmed: 26301632
Diabetes. 2008 Jan;57(1):77-85
pubmed: 17928396
Diab Vasc Dis Res. 2016 Jan;13(1):93-6
pubmed: 26449239
Nucleic Acids Res. 2012 Jan;40(1):37-52
pubmed: 21911355
Endocr Rev. 2017 Apr 1;38(2):145-168
pubmed: 28323921
PLoS One. 2015 Dec 21;10(12):e0145116
pubmed: 26690959
Cell. 2013 Apr 11;153(2):413-25
pubmed: 23582329
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
pubmed: 29074454
Obes Rev. 2015 Jan;16(1):1-12
pubmed: 25407540
Arch Med Res. 2011 Apr;42(3):244-51
pubmed: 21722822
Environ Pollut. 2019 May;248:66-73
pubmed: 30771749
Exp Biol Med (Maywood). 2014 Apr 9;239(8):954-965
pubmed: 24719379
J Comput Biol. 2017 Nov;24(11):1138-1143
pubmed: 28715235
Saudi Med J. 2005 Mar;26(3):373-5
pubmed: 15806201
J Clin Invest. 2019 Oct 1;129(10):4041-4049
pubmed: 31483293
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
Mol Cell Endocrinol. 2014 Jun 25;391(1-2):41-9
pubmed: 24784704
Clin Endocrinol (Oxf). 2014 May;80(5):677-84
pubmed: 23594269
Diabetologia. 2020 Jan;63(1):124-136
pubmed: 31659408
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell. 2017 Oct 5;171(2):372-384.e12
pubmed: 28942920
J Clin Invest. 2013 Jul;123(7):2764-72
pubmed: 23863634
Diabetes. 2017 Feb;66(2):347-357
pubmed: 27899485
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1787-1800
pubmed: 32460579
Annu Rev Pathol. 2019 Jan 24;14:211-238
pubmed: 30332561